Glucose Biosensors Market is Expected to Show Staggering Growth During the Forecast Period

Global Glucose Biosensors Market: Overview

Glucose biosensors are extensively being used for measuring concentration of glucose in diabetic patients. Proteins including nucleic acids, enzymes, and others are some of the popularly used biosensors to understand the glucose levels in a patient. The global glucose biosensors market is experiencing a growth spurt due to increasing number of diabetic patients across the globe. The World Health Organization (WHO) states that about 347 million people are diagnosed with high blood sugar levels across the globe. In light of this statistic, the organization also states that diabetes is expected to be the leading cause of death by the end of 2030. Needless to say that the increasing prevalence of diabetes in the world is likely to be the primary growth driver for the global glucose biosensors market in the near future.

Browse through Glucose Biosensors Market report to know what factors will shape the market by 2024: http://www.transparencymarketresearch.com/glucose-biosensors-market.html

The research report by Transparency Market Research presents a detailed explanation about the global glucose biosensors market. It explains the strengths, weaknesses, opportunities, and threats impacting the segments of the global market with the help of a SWOT analysis. Additionally, the report also includes unbiased opinions of market leaders to help readers gain a fresh perspective toward the changing market dynamics.

Global Glucose Biosensors Market: Key Trends

The growing need and an urgency amongst diabetics for better disease management is expected augment the demand for glucose biosensors. The two types of glucose biosensors available in the global market are amprometric glucose biosensors and fluorescence glucose biosensors. Of these, the demand for the former is expected to show steady demand in the global market due to its wide availability. Amprometric glucose biosensors oxidize glucose which leads to production of hydrogen peroxide. This is then identified by electrode, which aids the understanding of glucose concentration in the bloodstream.

However, tremendous innovation in the fluorescence technique is expected to bolster the growth of the fluorescent glucose biosensors segment as well. The demand for these biosensors is expected to show a gradual rise as they are known to measure the glucose concentration with utmost accuracy. Furthermore, the life of probe of fluorescence biosensors is higher than amprometric biosensor, which is expected to play an instrumental role in the helping this supporting this segment.

Global Glucose Biosensors Market: Regional Outlook

Geographically, the global glucose biosensors market is segmented into Asia Pacific, North America, Europe, the Middle East and Africa, and Latin America. Of these, North America is estimated to lead the global glucose biosensors market. The better and quicker adoption of technology in the region along with advantage of innovation are expected to keep North America at forefront of the global market. Analysts expect that North America glucose biosensors market will also be supported to growing prevalence of diabetes in the region.

Europe is also estimated to be a key contributor in the global market due to an ever-growing pool of geriatrics. The European Commission stated that 17.8% of the European population was over the age of 65 years in 2012. The uptake of glucose biosensors is expected to remain high across Europe as the region experience rise in the number of geriatrics. Asia Pacific too is estimated to present lucrative opportunities to the global market.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Glucose Biosensors Market by 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3235

Key Players Mentioned in this Report are:

Some of the leading companies operating in the glucose biosensors market are Abbott Point Of Care, Inc., Lifesensors, Inc., Animas Corporation, Medtronic Diabetes, AgaMatrix, Inc., Siemens Healthcare Diagnostics, Inc., Nova Biomedical Corp., LifeScan, Inc., M-Biotech Limited, and F. Hoffman-La Roche among others.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Prefilled Syringes Market: Need to Address Concerns over Needle Stick Injuries Drives the Demand

Prefilled Syringes Market: Snapshot 

Parenteral is one of the most commonly used route of drug administration, oral administration being the most preferred one. A steady rise in the development and availability of parenteral drugs has resulted in the increasing demand for several advanced drug delivery devices that promise cost containment as well as ease of administration.

This 187 page report gives readers a comprehensive overview of the Prefilled Syringes Market. Browse through 24 data tables and 104 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/prefilled-syringes-market.html

Prefilled syringes are one of the most rapidly expanding segments of the injectable drug delivery devices market. There are several benefits of prefilled syringes over traditional delivery systems: improved safety, ease of administration, accurate dosing, and reduced risk of contamination. These advantages form the basic foundation for the success of prefilled syringes and are likely to continue driving the market during the forecast period.

Technical advances in the sector, rapid growth in the biologics market, and the growing preference for self-administration using autoinjectors, prefilled syringes, and pen injectors are the key factors boosting the global market for prefilled syringes.

The global sales of prefilled syringes amounted to US$3.5 bn in 2015 and is projected to reach US$7.9 bn, expanding at a CAGR of 9.3% over the period of 2016 to 2024.

Glass Prefilled Syringes to Lose Market Share Despite being Most Preferred Segment 

Prefilled syringes are available in two key types – plastic (polymer) and glass – depending on the kind of material used to develop the barrel of the syringe. Despite the fact that the industry has been reporting a growing use of polymers by many manufacturers of syringes, glass is still considered to be the top-most choice and will continue to dominate the market in terms of volume as well as revenue. This is attributed to the fact that changing the perception of healthcare practitioners and manufacturers over the preference of glass over plastic is expected to be a rather gradual process. The segment of glass prefilled syringes is anticipated to lose market share toward the end of the forecast period, which will be replaced by plastic syringes. The latter is expected to grow at a CAGR of 10.8% from 2016 to 2024.

By application, the market is segmented into vaccines, monoclonal antibodies, and others. On the basis of distribution channel, the prefilled syringes market is categorized into hospitals, ambulatory surgical centers, and mail order pharmacies.

Japan Most Promising Market in APAC Prefilled Syringes Market 

Europe has maintained its position as the leading regional market for prefilled syringes in terms of volume (unit consumption) as well as revenue. However, the APAC market for prefilled syringes is anticipated to exhibit strong growth at a CAGR of 11.3% during the forecast period. The presence of leading drug manufacturers in the region requiring prefillable syringes and the high conversion rate from vials to prefilled syringes are the primary factors likely to support the growth of the APAC market.

Asia Pacific is perceived as a follower rather than a leader when it comes to the development and adoption of new technologies. Although the prefilled syringes market is presently in its stage of infancy in APAC, factors such as improving economic conditions, the rising purchasing power of the people, the growth in awareness regarding the advantages of prefilled syringes, and the presence of a large patient suffering from various chronic diseases are expected to drive the market to register a double-digit CAGR. In Asia Pacific, Japan accounts for the major share in the market by revenue as well as volume.

Get accurate market forecast and analysis on the Prefilled Syringes Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1131

Major players in the global prefilled syringes market include Becton Dickinson & Co., Gerresheimer, Medtronic, Baxter International, SCHOTT AG, West Pharmaceuticals, Vetter International, Unilife Corporation, Stevanato Group, and Terumo Corporation.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Vertebroplasty and Kyphoplasty Market: Projected to Gain Significant Value by 2025

Vertebral fracture is one of the major medical conditions in economies in the West. Pain and deformity, impacting the quality of life, are major problems that entail this type of fracture. Medical therapy is the cornerstone of vertebral body fracture management, excluding neurological impairment, including bed rest, rehabilitation, orthoses, and analgesics. Effectiveness of such treatment modalities is observed in a majority of patients. Kyphoplasty and vertebroplasty are two percutaneous minimally invasive methods for vertebral augmentation, developed to manage symptomatic fractures without neurological impairment, for application of cement into vertebral body. Kyphoplasty was introduced to help realign the spine and manage kyphotic deformity. It includes placing an inflatable balloon device (bone tamp) percutaneously into vertebral body. The U.S. FDA approved this procedure in 1998. The inflation of bone with liquid enables correction of kyphosis and restoration of vertebral height. The cavity produced after inflation is filled by an injection of polymethylmethacrylate (PMMA).

Browse through Vertebroplasty and Kyphoplasty Market report to know what factors will shape the market by 2025: http://www.transparencymarketresearch.com/vertebroplasty-kyphoplasty-market.html

In order to manage an aggressive, painful hemangioma of vertebral body, vertebroplasty (a minimally invasive percutaneous method) was introduced with an aim to inject PMMA cement percutaneously into the collapsed vertebral body to strengthen it, under imaging guidance. Kyphoplasty and vertebroplasty have been widely accepted across the globe. These methods help in managing patients without neurological impairment, who suffer from otherwise unmanageable pain resulting from vertebral compression fractures due to osteolytic lesions and osteoporosis within the vertebral body. These procedures depend on fracture’s mechanical stabilization, produced by injecting PMMA cement into fractured vertebra.

Limitations in traditional techniques for treating vertebral compression fractures drive the global vertebroplasty and kyphoplaty devices market. These advanced procedures result in stabilization, pain relief of the fracture, avoiding downward spiral of untreated osteoporosis. Soaring geriatric population has resulted into a rise in the number of patients with osteoporosis. Kyphoplasty and vertebroplasty require shorter surgical time, providing discharge to patients in less than a day. These procedures require general anesthesia and enable the patients to return soon to their daily routine. No bracing is needed for these procedures. These factors are expected to fuel market growth in the near future. In contrast, chances of another fracture occurrence and complications such as post-surgery infection and bleeding are expected to retrain the global vertebroplasty & kyphoplasty devices market.

The vertebroplasty & kyphoplasty devices market has been categorized based on surgery, product, end-user, and region. In terms of surgery, the market has been segmented into vertebroplasty and kyphoplasty. Based on product type, the market has been categorized into devices, needles, cement mixing & delivery devices, X-ray equipment, and balloons. The devices segment has been sub-segmented into vertebroplasty and kyphoplasty devices. In terms of end-user, the vertebroplasty and kyphoplasty market has been segmented into hospitals, diagnostic centers, research institutes, and others. Increasing prevalence of vertebral compression fractures (VCF) owing to increasing geriatric population is fueling demand for vertebroplasty and kyphoplasty devices.

In terms of region, the vertebroplasty and kyphoplasty devices market has been segmented into Asia Pacific, Europe, Middle East & Africa, North America, and Latin America. Increasing number of surgical procedures has made North America the most lucrative market for vertebroplasty and kyphoplasty devices. In addition, high economic contribution of healthcare, availability of well-established health care infrastructure, and patient compliance drive demand for vertebroplasty and kyphoplasty devices in the region. Europe is another lucrative market for vertebroplasty and kyphoplasty devices due to technological advancements in the health care sector in the region. Asia Pacific is projected to register higher growth rate than North America and Europe driven by growing opportunities in emerging economies such as India and China.

Get accurate market forecast and analysis on the Vertebroplasty and Kyphoplasty Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23156

Key players in the global vertebroplasty and kyphoplasty devices market include DePuy Synthes, CareFusion Corporation, Alphatec Spine, Inc., G-21 s.r.l., Medtronic, Inc., Stryker Corporation, Osseon LLC., Taeyeon Medical Co., Ltd., BMK Global Medical Company, Globus Medical, Inc., and SOMATEX.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Jet Lag Therapy Market Outlook: Rising Number of Air Travelers Rises the Demand

Jet lag is a group of various symptoms shown by physiologic alterations that occur when the body is shifted into a new time zone. Travel tiredness and exhaustion is a more complex addition of various physiologic, psychological, and environmental factors that arise during an individual trip, collecting over the course of a season. Jet lag has been observed in pilots, air travelers, cabin crew members, physicians, and athletes. The effect of travel between various continents and extensive travel by passengers can result in physiologic upset and a complicated set of mental and physical symptoms. Currently, there is a culture of disregard and lack of knowledge regarding the negative effects of jet lag on the performance and well-being of a person. In addition, the key physiologic metric that guides jet lag treatment is difficult, and thus make limitations to therapeutics available today. Jet lag is a common problem for many air travelers. Currently, there is no standard definition of this disorder, but most studies include symptoms of weakness, fatigue, decreased daytime alertness, difficulty concentrating, memory problems, daytime sleepiness, and lack of energy after a long flight. Jet lag disorder is generally temporary and usually does not need medication and treatment. Within few days the condition often improves although sometimes symptoms last longer. However, if an air traveler is continuously bothered by jet lag, medications or light therapy to improve jet lag may be prescribed by a doctor.

Browse through Jet Lag Therapy Market report to know what factors will shape the market by 2025: http://www.transparencymarketresearch.com/jet-lag-therapy-market.html

The global jet lag therapy market has been segmented based on product type, end-user, and region. In terms of product type, the market has been categorized into prescription medication, jet lag wearable devices and light box, and melatonin and herbal medication. The melatonin and herbal medication segment holds the largest share of the jet lag therapy market due to increasing incidence of jet lag globally. Based on end-user, the market has been classified into athletics, journalists & bloggers, business executives, pilot & cabin crew, and other travelers. The business executives segment held the largest share of the market due to excessive traveling of business persons from one region to another on business.

Geographically, the jet lag therapy market has been segmented into five major regions: North America (U.S. and Canada), Europe (Germany, France, U.K., etc.), Asia Pacific (Australia, China, Japan, India, etc.), Latin America (Brazil, Mexico, etc.), and Middle East &Africa (GCC Countries, South Africa, etc.). North America is the leading market for jet lag therapy in terms of revenue, followed by Europe. The U.S. holds the largest share of the market in the region. Asia Pacific and Latin America are emerging markets, which are expected to witness strong growth during the forecast period from 2017 to 2025. Strong growth in these regions is attributed to increasing air travelers, rising health care industries, and increase in government investment to develop health care infrastructure. The jet lag therapy market in countries such as China, India, and Brazil is projected to expand at high growth rate during the forecast period due to increase in awareness among the population about jet lag and its therapy.

Other factors that drive the jet lag therapy market are rising number of air travelers, convenience of direct purchase, high adoption and acceptance in developing markets, and innovations and developments in therapy. The market is also experiencing certain restraints such as stiff competition among existing players, high possibilities of substance abuse and addiction, complications and severity involved in taking wrong medications due to misdiagnosis or incorrect self-diagnosis, and lack of awareness among the population in developing and underdeveloped economies.

Get accurate market forecast and analysis on the Jet Lag Therapy Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22991

Major players operating in the jet lag therapy market include Ayo (Novalogy), The Litebook Company Ltd., Lumie, Lucimed S.A., Nature Bright, Northern Light Technologies, Re-Time Pty Ltd., and Chrono Eyewear BV.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Increasing Adoption for Advanced Implants by Physicians to Drive Absorbable Nasal Implant Market

Airway homeostasis is a crucial procedure controlled by nose. The infection or inflammation of sinuses resulting in the weakness of nasal lateral wall has significant effect on quality of patient’s life. Nasal obstruction or nasal valve collapse is usually caused due to rhinoplasty, aging, congenital abnormalities, and nasal trauma.  It is often untreated or undiagnosed due to lack of treatment awareness. Absorbable nasal implants are available in the form of springs, spacer, sponges/foams, and gels. These are gaining momentum due to complications associated with the removal of non-absorbable implants. Nasal reconstruction surgeries, such as rhinoplasty and septoplasty, result in loss of cartilage and require secondary surgeries to remove the non-absorbable implants. Absorbable nasal implants reduce the need of reconstruction of cartilage pieces and offer a structural support during the surgery healing period. These implants provide immediate scaffold support and have no long-term complications or side effects.

Browse through Absorbable Nasal Implant Market report to know what factors will shape the market by 2025: http://www.transparencymarketresearch.com/absorbable-nasal-implant-market.html

Technological advancements for the construction of nasal absorbable implants with reduced irritation or side effects is seen as a trend among the major market players. Relief from nasal congestion or stiffness, enhanced ability of respiration due to cleared lateral nasal passage, less trouble in sleeping, increasing adoption for advanced implants by physicians, and increasing patient demand for implant needing no secondary removal surgeries are anticipated to drive the global absorbable nasal implant market. However, stringent regulatory guidelines, subconscious awareness about implant creating discomfort, mild pain or irritation in some cases are expected to restrain the global absorbable nasal implant market.

The global absorbable nasal implant market has been segmented based on device type, material type, and end-user. In terms of product type, the market has been classified into drug eluting implants and non-drug eluting implants. Drug eluting implants are widely used in nasal surgical treatments. Hence, the segment is expected to account for the largest share of the global absorbable nasal implant market during the forecast period. Drug eluting implants are sub-segmented into corticosteroid eluting implants, antibiotics eluting implants, and others. Based on material type, the market has been divided into polymer implant, carboxymethylcellulose (CMC) implant, and others. Polymer implants are made of bio-absorbable polymers such as poly-lactic acid (PLLA). In terms of end-user, the market has been categorized into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment is anticipated to hold largest market share due to high patient preference, skilled physician availability, and proper infrastructure.

In terms of region, the global absorbable nasal implant market has been divided into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is expected to expand at a high CAGR owing to factors such as large patient pool, adoption of better health care facilities, and increasing awareness about advanced nasal reconstruction procedure among the end-users. North America is projected to dominate the global absorbable nasal implant market due to substantial investments in research and development for efficient treatment options with reduced side effects or need of secondary surgical procedures.

Absorbable nasal implants offer advantages such as regular mucosal healing with no delayed post-operative cosmetic changes, or adverse reaction. These are often operated with minimally invasive techniques. Increasing efficacy of drug eluting absorbable implants with reduced physiological tissue adverse rejection offers large opportunity in the global absorbable nasal implant market. Major market players are making significant investment in the research in invention of septal reconstruction absorbable implant with reduced follow-up and offering mechanical and aesthetic stability.

Get accurate market forecast and analysis on the Absorbable Nasal Implant Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22967

Key players in the global absorbable nasal implant market are Spirox, Inc., Intersect ENT, Inc., Mentor Worldwide LLC, Smith & Nephew, Inc., ArthroCare Corporation, Acclarent, Inc., Pfizer, Inc., and Stryker Corporation, among others.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Regulatory Affairs Outsourcing Market with Value of 11.5% CAGR will Rise to US$5.7 Bn by 2023

Economic and competitive pressures in the healthcare industry continue to motivate life sciences companies to explore ways of cutting costs across operations and increase their focus on product innovations, research activities, and improved turnaround time of deliverables. Companies aspiring to widen their global reach are increasing investments on R&D activities and new products are entering clinical trials and the market at a rapid pace. Undertaking regulatory affairs and the maintenance of vast volumes data generated during the process can be a daunting task for companies having a vast product portfolio and operations spread across diverse regional markets.

This 76 page report gives readers a comprehensive overview of the Regulatory Affairs Outsourcing Market. Browse through 10 data tables and 18 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/global-regulatory-affairs-outsourcing-market.html

These factors have encouraged an increased rate of outsourcing of regulatory affairs across life sciences industries in the past few years. Recent findings by Transparency Market Research state that the global regulatory affairs outsourcing market will exhibit a healthy 11.5% CAGR from 2015 to 2023. As a result, the market, which had a valuation of US$1.9 bn in 2014 will rise to US$5.7 bn by 2023.

Clinical Trial Application and Product Registration Services to be Key Enabler of Growth

Of the key regulatory affair services outsourced by life sciences companies, regulatory writing and publishing is presently the largest market segment, accounting for a share of more than 40% across the global market in 2014. Owing to the diverse and continuously changing regulations across local, regional, national, and international markets, companies spend a vast share in their overall regulatory investments for timely updating data such as regulatory submissions and standard operating procedures. It is owing to this fact that the segment of regulatory writing and publishing leads the regulatory affairs outsourcing market.

Over the next few years, however, the market for regulatory affairs outsourcing is witness the highest gains from the clinical trial applications and product registration segment. Factors such as patent expiries and the rising prevalence of a number of chronic, viral, and bacterial diseases have prompted biopharmaceutical companies in the development of a large number of new products. With the rising number of products in clinical trials, the demand for clinical trial application and product registration services is expected to substantially rise in the next few years.

Low-cost Clinical Trial Centers in Emerging Economies to be Key Enabler of Growth

In the years to come, regulatory affairs service providers in emerging economies across regions such as Latin America and Asia Pacific are expected to bag the most numbers of outsourcing projects across the globe. An increased number of biopharmaceutical companies are using emerging economies as a launch pad for their venture in larger markets such as North America and Europe.

Get accurate market forecast and analysis on the Regulatory Affairs Outsourcing Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3528

Product development, research, and commercialization units are being set up at an increased rate across emerging economies owing to cheap resources and raw material costs. The vast population base of Asia Pacific also makes it a lucrative regional market for the medical industry. These factors are acting in favor of the regulatory affairs outsourcing markets in these regions and will help strengthen the market’s foothold in the next few years. As a result, the market for regulatory affairs outsourcing market in emerging economies will offer the most lucrative and sustained growth opportunities for the global market. The market is expected to expand at a 15.8% CAGR in Asia Pacific and 11.1% CAGR across Latin America from 2015 to 2023.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Breast Cancer Therapeutics Market to Focus on Developing Companion Diagnostics Models

Changing Lifestyles Necessitate Change in Game Plan of Breast Cancer Therapeutics Providers

The changing lifestyles and the growing issue of obesity have heightened the risk of breast cancer amongst women in recent years. Statistics indicate that breast cancer has become the second largest cause of fatalities across the globe. Thus, the increasing number initiatives to raise awareness about this deadly disease and treat patients for this disease has boosted the global breast cancer therapeutics market. The increasing awareness amongst patients about the disease and improving accessibility to premium treatments has also augmented the sales of various drugs in this market. Effective research and development for new treatments to efficiently treat breast cancer is also expected to change the game for this market.

Browse through Breast Cancer Therapeutics Market report to know what factors will shape the market by 2023: http://www.transparencymarketresearch.com/breast-cancer-therapeutics-pipeline-analysis-market.html

Transparency Market Research forecasts that the global breast cancer therapeutics market is expected to be worth US$16.21 bn by 2023 as compared to US$7.17 bn in 2014, surging at a CAGR of 8.4% between 2015 and 2023. The drastically changing reproductive patterns are also responsible for soaring revenue earnings of the breast cancer therapeutics market. The delayed childbearing age, reduced breastfeeding periods, intake of oral contraceptives, and resorting to hormonal therapies to solve other medical conditions is also contributing towards the growth of this market.

Higher Percentage of Survivors in North America Puts Region in the Lead

A study conducted by World Cancer Research Fund International (WCRF) stated that North America has the highest percentage of breast cancer survivors after diagnoses, while it is the lowest in the developing countries of Asia and Africa. However, breast cancer continues to be a serious health concern in South America, Africa, and Asia.

WRCF also states that North America has a high incidence of breast cancer, however, the breast cancer therapeutics market is progressing in this region due to supportive insurance schemes meted by the government. The overall North America breast cancer therapeutics market is expected to surge at 7.3% CAGR between 2015 and 2023 during the forecast period. The risks of post-treatment complications and relapse are the only two key factors hampering this regional market.

Accurate Diagnosis through HER2 Inhibitors Increases Preference for the Drug Class

Amongst the various drug classes, the HER2 inhibitors segment was the leading segment in 2014. During the forecast period, the HER2 inhibitors segment is expected to expand at a CAGR of 6.2% due to their ability to deliver accurate diagnostics. HER2 inhibitors are used in case of metastatic breast cancer (MBC) patients who have undergone a minimum of two chemotherapeutic schedules of taxane and anthracycline. All of these factors are expected to raise the market opportunity of the HER2 inhibitors segment to a significant amount by the end of forecast period.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Breast Cancer Therapeutics Market by 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5678

The key players operating in the global breast cancer therapeutics market are GlaxoSmithKline plc, Eli Lilly and Company, AstraZeneca plc, Pfizer, Inc., F. Hoffmann-La Roche Ltd., Puma Biotechnology, Novartis International AG, and Sanofi S.A. Companies are focusing on research and development to launch new products along with acquiring small companies to improve the existing line of products. However, these companies are governed by strict regulatory framework, which often causes delay in launching products.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Surgical Microscope Market is Expected to Develop Substantially Due to Adoption of Microsurgeries

A surgical microscope or operating microscope is an electrically or mechanically operated optical microscope designed specifically to perform microsurgeries in a surgical setting. It provides magnification (typically ranging from 4x–40x), illuminated image, and stereoscopic vision of the surgical area. Surgical microscopes mainly offer a strain-free procedure to surgeons. Their components are designed to sterilize or disinfect easily to avoid cross infection. The modern operating or surgical microscope can be placed on a surface such as a table top, mounted on a stand, or worn by the surgeon on the head. In a surgical suite with limited space, it can be hung on the wall or ceiling to conserve floor space. It enables students, staff, as well as the patient to gain a better view of the target site, along with the surgeon.

Browse through Surgical Microscopes Market report to know what factors will shape the market by 2025: http://www.transparencymarketresearch.com/surgical-microscopes-market.html

The global surgical microscope market is expected to develop substantially due to the rising prevalence of chronic diseases and adoption of microsurgeries or minimally invasive surgeries. Demand for them is predicted to drive the market for surgical microscopes as they play a critical role in these surgeries. The geriatric population is highly susceptible to several chronic disorders and age-related problems, which is likely to aid the expansion of the market. Furthermore, advancements in health care infrastructure and research & development in life sciences are predicted to drive the market. Rapid technological advancements in surgical microscopes regarding visibility, portability, stability, adoption of fluorescence image-guided surgery (FIGS), and addition of innovative features such as the red reflex stability, augmented microscopy, and wide angle view are anticipated to propel the market during the forecast period.

However, the high cost of the microscope leading to its low acceptance may restrain the market in some regions, apart from the heavy custom duties on medical instruments and excise tax implementations by the U.S. government. The dearth of skilled professionals and inadequate technical knowledge may lead to sluggish development of the global surgical microscope market.

The market can be segmented on the basis of application into the following categories: ophthalmic surgeries, neurosurgery, ENT surgeries, plastic & reconstructive surgery, spine surgery, dentistry, gynecology (also colposcopes for diagnostics in gynecologic treatments), and urology. Ophthalmology is the dominant segment due to growing concerns over vision & eyesight, increasing prevalence of eye disorders, and rising population opting for ophthalmology surgeries globally. The ENT segment is projected to advance significantly owing to the mounting preference for minimally invasive surgeries for ENT, high prevalence of disorders such as sinusitis, and supportive reimbursement plans. In terms of end-user, the global surgical microscope market can be divided into the following groups: hospitals, specialty clinics, and ambulatory surgical centers.

Geographically, the market can be distributed over five major regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the surgical microscope market, owing to the sophisticated health care services and supportive reimbursement policies for medical treatments enabling greater usage of the instrument in the region. Moreover, the rising incidence of chronic diseases and higher adoption of minimally invasive surgeries play a role too. Asia Pacific is estimated to expand rapidly on account of the increasing geriatric population, advancements in health care facilities, and supportive medical reimbursement programs in emerging countries such as India and China. Asia Pacific and Latin America are lucrative target areas for major key players of the surgical microscope market.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Surgical Microscopes Market by 2025: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23702

These include Carl Zeiss AG, Leica Microsystems (Danaher Corporation), Topcon Medical Systems, Inc. (Topcon Corporation), Haag-Streit Group, Novartis AG, Takagi Seiko Co Ltd., and Global Surgical Corporation.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Growing Popularity of Multipotent Stem Cells Accentuates Autologous Tissue Repair Market

Global Autologous Tissue Repair Market: Overview

The growing therapeutic applications of regenerative medicines has made a mark in the area of wound care such as those in refractory injuries and chronic wounds. With rapid advances in regenerative medicines, stem cells have gained increased popularity across autologous tissue engineering methods. Apart from wide applications in surgical medicine, the evolution of the market has influenced multiple clinical areas such as cardiovascular medicines, refractory wound care, and orthopedics. Prominent clinical applications of autologous tissue repair include bone repair, cardiac repair, neural repair, skeletal muscle repair, and pediatric vascular conduits.

Browse through Autologus Tissue Repair Market report to know what factors will shape the market by 2024: http://www.transparencymarketresearch.com/autologus-tissue-repair-market.html

Technological advances have led researchers and clinicians in isolating, purifying, and re-injecting patient’s cells in refractory injuries with significant reliability and efficacy. In recent years, autologous tissue repair methods have emerged to be highly promising in abdominal wall reconstruction associated with chronic infections. These are mainly caused by intra-abdominal catastrophes and due to several technical constraints are difficult to close.

The report offers in-depth insights into the key drivers and restraints, notable trends and emerging applications, technological advancements, market share and size of various segments, and competitive landscapes. The insights offered in the study are useful in evaluating lucrative avenues across various regions.

Global Autologous Tissue Repair Market: Trends and Opportunities

The growing prevalence of intractable ailments in a rapidly increasing geriatric populations across various regions and the increasing number of road accidents are the key factors driving the analogous tissue repair market. In addition, the growing prominence of autologous tissue repair therapies in chronic wound care and orthopedics has boosted the autologous tissue repair market. The increasing adoption of components separation technique (CST) for autologous repair of abdominal wall defects is anticipated to catalyze the market growth.

A growing number of therapeutic autologous therapies can also be accessed using point-of-care setting, thereby accentuating the autologous tissue repair market. However, the high cost of availing autologous tissue repair therapies is likely to hinder the market to an extent. In addition, strict regulatory compliance for the approval of these therapies has impeded the growth of the market in various regions. Nevertheless, recent progress in stem cell-based tissue engineering has further expanded the autologous approaches to tissue engineering. For instance, recent research in intervertebral disc regeneration shows that stem cells can be used to treat slipped discs. Furthermore, the growing popularity of multipotent stem cells is expected to accentuate the autologous tissue repair market. Clinical studies on improving the efficacy of CST and other similar methods are expected to create exciting opportunities in the coming years.

Global Autologous Tissue Repair Market: Regional Outlook

North America is a prominent market for the autologous tissue repair market. The substantial growth of this regional market is attributed to the large scale presence of several players in the region. Europe is another prominent regional market and the extensive demand for autologous tissue repair is propelled by a large chunk of elderly population.

Asia Pacific is expected to grow at an impressive pace. The impressive growth of the market is driven by advances in healthcare infrastructure, frequent innovative product launches, and the swift pace of industrialization rate in emerging countries in the region. A major chunk of the demand is expected to come from countries such as India, Japan, Malaysia, and China.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Autologus Tissue Repair Market by 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4680

Global Autologous Tissue Repair Market: Companies mentioned in the report

Some of the prominent companies operating in the autologous tissue repair market are Vericel Corporation, Matricel GmbH, and Orthocell Limited. Several companies are launching innovative products and entering into partnerships to consolidate their shares across major regions.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Development of the Healthcare Sector and Infrastructure Develops Global Biological Implants

Global Biological Implants Market: Overview 

The global biological implants market is expected to grow at a significant pace in the next few years. The rising growth prospects in several emerging nations across the globe is predicted to encourage the growth of the overall market in the coming years.

Browse through Biological Implants Market report to know what factors will shape the market by 2024: http://www.transparencymarketresearch.com/biological-implants-market.html

The research report on the global biological implants market offers a detailed overview and highlights the key factors that are predicted to influence the market’s growth in the next few years. In addition, the product segmentation, regional outlook, and the key applications of biological implants have been presented in the research study to offer a clear understanding of the market. A thorough view of the vendor analysis has been given, along with a list of the leading players operating in the biological implants market across the globe.

Global Biological Implants Market: Drivers and Restraints 

The development of the healthcare sector and infrastructure is one of the key factors expected to encourage the development of the global biological implants market in the forecast period. In addition, the advancements in the technology and the rising awareness among consumers regarding the benefits of biological implants are likely to accelerate the growth of the overall market in the next few years. The rising number of road accidents and the increasing number of sports injuries are another major factors that are estimated to supplement the marker’s growth in the near future.

On the other hand, the global market for biological implants is estimated to face several growth barriers throughout the forecast period. In addition, the high cost of implants is projected to restrict the growth of the market in the coming years. Nevertheless, the rising focus of key players on introducing cost-effective products is predicted to generate promising opportunities in the next few years.

Global Biological Implants Market: Region-wise Outlook 

The global market for biological implants has been classified on the basis of geography into Asia Pacific, Latin America, Europe, North America, and the Middle East and Africa. As per the research study. Emerging nations in Latin America and Asia Pacific are expected to offer promising growth opportunities for key players in the next few years. The robust growth of these two regions can be attributed to the tremendously rising population and the improving economic conditions. In addition, the presence of high unmet medical requirements and the development of the healthcare sector are estimated to accelerate the market’s growth over the forecast period.

On the other hand, North America and Europe are estimated to witness steady growth in the next few years, owing to the uncertain economic conditions. As a result, the manufacturers, across the globe are anticipated to focus on developing economies in order to expand their market presence. Additionally, the rising disposable income of consumers, especially in these nations are projected to encourage the growth of the biological implants market in the next few years.

Key Players Mentioned in the Research Report are: 

The global biological implants market is predicted to witness a significant growth throughout the forecast period. The expected rise in the number of players is likely to strengthen the competitive landscape of the market in the coming years. Some of the leading players operating in the biological implants market across the globe are Biomet, Inc, Globus Medical, Integra Lifescience Corporation, Stryker Corporation, Regeneration Technologies, Inc., Alphatec Spine, Inc., C.R. Bard, Allergan, and NuVasive.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Biological Implants Market by 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4618

The rising focus of these players on research and development activities and innovations is likely to encourage the overall growth of the global biological implants market throughout the forecast period. The research study offers a thorough overview of the vendor analysis and throws light on the policies and strategies that have been adopted by them to sustain in the market. In addition, the company profiles of the players have been included in the study to offer a clear understanding to new entrants and readers.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Growing Prevalence of High Blood Pressure will Boost Intracranial Pressure Monitors Market

As the global intracranial pressure monitors market undergoes a paradigm shift from invasive to non-invasive devices, manufacturers are facing intense competition, prompting them to focus on technological advancements. Leading players such as Integra LifeSciences Corp., Medtronic Inc., and Codman & Shurtleff Inc. are aggressively integrating advanced technologies in their products. In line with this trend, companies are now racing to introduce next-generation products in the market.

This 74 page report gives readers a comprehensive overview of the Intracranial Pressure Monitors Market. Browse through 6 data tables and 26 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/intracranial-pressure-monitors-market.html

Looking forward, untapped markets in emerging economies are likely to offer lucrative opportunities to participants. Entering into strategic partnerships with local players will help major companies to seize better shares in the market.

Intracranial Pressure Monitors Gain Impetus from Rising Incidence of Traumatic Injuries

“The frenzied lifestyle of people across the world has increased the frequency of traumatic injuries and augmented the prevalence of strokes, thereby escalating the demand for intracranial pressure monitors,” says an analyst at TMR. Cranial injuries and head trauma are mostly caused by road and industrial accidents, which lead to death or permanent disability for hundreds of individuals every year. Elevated intracranial pressure causes around 2 casualties in every 10 cases of head injuries across the world. The increasing reports of brain injuries in adults as well as pediatric patients have also fueled the demand for intracranial pressure monitoring significantly.

Strokes are another prominent factor that has escalated the application of these pressure monitors. Large hemispheric strokes increase the cerebral perfusion pressure and enhance the mean flow velocity of the middle cerebral arteries in the patient, raising the intracranial pressure. The growing prevalence of high blood pressure among people across the world has augmented the frequency of strokes, thereby boosting the demand for intracranial pressure monitors substantially.

Hitherto, the risk associated with the invasive nature of intracranial pressure monitors, such as bacterial infections, hampered their adoption across the world. The reports about cerebrospinal fluid infection, which sometimes leads to fatal consequences, have limited the application of intracranial pressure monitors significantly.

Despite North America’s Claim on Leadership, Asia Pacific to Emerge Prominently

Despite of being hindered by these factors, the global market for intracranial pressure monitors has a bright future ahead of it. TMR expects this market to expand at a CAGR of 6.30% during the period from 2015 to 2023, with market opportunity swelling from US$0.94 bn in 2014 to US$1.63 bn by the end of the forecast period.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Intracranial Pressure Monitors Market by 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6445

Currently, North America holds the largest share in this market and will continue to lead over the next few years. However, the future of this market lies in Asia Pacific. The rapid increase in geriatric population, rising prevalence of cerebrovascular disorders, and escalating healthcare expenditure in this region together are likely to offer rewarding opportunities to participants in the coming years.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Growing Geriatric Population and Changing Healthcare Infrastructure Drives Anatomic Pathology Market

Anatomic pathology plays a vital role in the study, diagnosis, and treatment of diseases. It includes the examination of surgical samples extracted from the infected part of the body, i.e., biopsy and the examination of the whole body to diagnose the disease, i.e., autopsy. The organs or tissues are examined on the basis of microscopic, macroscopic, biochemical, immunologic, and molecular tests in order to diagnose the disease. Anatomic and clinical are the two branches of pathology. Clinical pathology involves the diagnosis of diseases by examination of blood, serum, or other body fluids. The worldwide market for anatomic pathology is gaining substantial momentum due to the rising use and effectiveness of biomarkers in diagnosing various disease including cancer.

Browse through Anatomic Pathology Market report to know what factors will shape the market by 2025: http://www.transparencymarketresearch.com/anatomic-pathology-market.html

The global anatomic pathology market is driven by the increasing incidence and prevalence of chronic diseases including infectious diseases, kidney or liver diseases, and cancer. Cancer cases are increasing exponentially worldwide, with maximum patients suffering from lung, prostate, colorectal, and breast cancer. Biomarkers are presenting a promising approach in the diagnosis of cancer and other diseases. The elevating use of biomarkers for the diagnosis of diseases is predicted to considerably accelerate the development of the anatomic pathology market. Additionally, the growing global geriatric population also plays a contributing role, as elderly individuals are more prone to infectious diseases, thereby demanding proper diagnosis for effective treatment. The developing health care infrastructure is also motivating the global anatomic pathology market.

With the rising number of chronic diseases, demand for anatomic pathology services and therefore biopsies is also increasing. Any failure to deal with the large number of biopsies or comply with recommendations for cancer cases or other sample handling or additional testing may pose a major challenge. Improvement in turnaround time is another critical element of management, which may restrain the market.

The global anatomic pathology market can be segmented on the basis of product type & services into the following categories: consumables, reagents, instruments, and services. The instruments segment can further be divided into the following sub-categories: tissue processors, slide strainers, microtomes, and others. In terms of application, the market can be split into the following groups: drug discovery, disease diagnosis, and others. Based on end-user, the market can be classified into the following sections: hospitals, diagnostic laboratories, and research organizations.

Geographically, the global anatomic pathology market is distributed over five major regions: North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. North America holds a major share in the market due to the growing elderly population, prevalence of lung cancer & other chronic diseases, increasing investments by government & academic research centers in diagnostic research, high attention to biomarkers research, and the presence of major players in this region. Asia Pacific is anticipated to witness growth during the forecast period due to the presence of emerging economies such as India, China, and Japan. The rising population in these countries and thereby the increasing chronic diseases & improved standards in health care services, growing demand for superior medical care, and the mounting awareness regarding the importance of anatomic pathology investigation among health practitioners are some of the factors motivating the market.

Get accurate market forecast and analysis on the Anatomic Pathology Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23774

Key players in the anatomic pathology market include Leica Microsystems (Danaher Corporation), Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, Sakura Finetek USA, Quest Diagnostics Incorporated, NeoGenomics Laboratories, Inc., and Laboratory Corporation of America Holdings.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Angioplasty Balloons Market to Progress at 3.50% CAGR by 2023 due to Steady Launch of New Products

Balloon angioplasty is a minimally invasive procedure that widens the obstructed blood vessels. This report is on global angioplasty balloons studies the current and future prospects of the market. The report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments included in the study. This section also provides the overall information and data analysis of the global angioplasty balloons market with respect to the leading market segments based on type of balloons, material used, and geography.

This 86 page report gives readers a comprehensive overview of the Angioplasty Balloons Market. Browse through 9 data tables and 19 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/angioplasty-balloons-market.html

New entrants in the global angioplasty balloons market can expect to find a highly dynamic market that includes a number of companies with diversification in vendor sizes. The key players - Boston Scientific, Cordis Corporation, and Abbott Laboratories - had collectively garnered a share of 71.7% in 2014 in terms of market value.

Additionally, the market growth rate is deemed to be too slow to create enough scope for new players to enter. Meanwhile, the degree of competition in the angioplasty balloons market is expected to remain high till 2023, owing to majority of the market being dominated by a few key players. These companies are locked in a race for new product launches and fast innovations.

The global market for angioplasty balloons is expected to progress at a CAGR of 3.5% in terms of revenue within the forecast period of 2015 to 2023. The revenue is expected to reach US$1.93 bn by the end of 2016 and US$2.55 bn by the end of 2023.

Drug Coated Angioplasty Balloons Gaining Demand

The report shows that normal balloons are expected to dominate the revenue generation among all angioplasty balloons. By the end of 2023, this segment’s revenue is expected to reach US$1.57 bn. However, drug coated angioplasty balloons are expected to gain massively in terms of popularity and usage. This segment is expected to progress at a CAGR of 8.2% from 2015 to 2023.

From a geographical standpoint, the demand for angioplasty balloons is led by North America, followed by Europe. By the end of 2023, the revenue generated by the North America angioplasty balloons market is expected to reach US$993.70 mn. The demand for angioplasty balloons is expected to expand in the Asia Pacific region at a CAGR of 5.3% from 2015 to 2023, which will be the leading growth rate among all regions for the forecast period.

Coronary Artery Disease on the Rise; Demand for Angioplasty Balloons Follows

“According to the CDC, nearly 610,000 deaths have occurred each year in the U.S. alone due to heart diseases in recent years. This number is expected to increase even further,” states a TMR analyst. He adds, “There were nearly 8 mn people in the U.S. suffering from peripheral artery disease in 2011. These numbers are also set to increase over time, due to factors including the fast increasing geriatric population, the rising number of diabetics and obese citizens, and the general increase in negative lifestyle choices and high stress levels. These numbers only point to a growing demand for medical devices, operative equipment, and implants.”

With the number of coronary surgeries expected to increase drastically in the coming years, the demand for angioplasty balloons will likewise show increments.

High Competition Reduces Angioplasty Balloon Prices, Cuts Revenues

Although the rate of entry by new angioplasty balloons manufacturers is moderate, the existing players have recently been adopting extreme pricing strategies to gain market penetration and share. The price cuts they impose on angioplasty balloons is getting them more users, but is drastically reducing the overall revenue generated in the market from a global standpoint.

As stated by Healing Hearts, the prices of angioplasty balloons along with other equipment have reduced by almost 40% in the last decade in India, one of the major destinations for medical tourism in the world. This is severely hurting the scope of research and development efforts hosted by leading players and is expected to hamper the market growth rate considerably in the near future.

Get accurate market forecast and analysis on the Angioplasty Balloons Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5627

“Manufacturers can instead focus on the release of new products currently in the pipeline. The success of these products will greatly improve the demand for angioplasty balloons and the overall growth rate of its global market,” states the analyst.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Increasing Demand of Coagulation Testing Drives the Growth of Anti-Thrombin III Testing Market

Anti-thrombin III is a naturally occurring inhibitor of blood coagulation that regulates the coagulation cascade. Anti-thrombin III is the type of serine protease inhibitor that inhibits the production of thrombin and other activated serine protease coagulation systems such as factor Xa, IXa and kallikrein. It is an α2-globulin member of the Serpin group and commonly synthesized in liver and is found in plasma and extra vascular sites. Anti-thrombin III influences the inflammatory processes via inhibition of actin polymerization. Testing for the Anti-thrombin II factor is helpful for the patients with recurrent deep vein thrombosis and pulmonary emboli are treated with the anti-thrombin III. In addition, anti-thrombin III testing is also used to treat the conditions such as arterial and venous thrombosis.

Browse through Anti-Thrombin III Testing Market report to know what factors will shape the market by 2023: http://www.transparencymarketresearch.com/anti-thrombin-testing-market.html

The market of anti-thrombin III can be segmented on the basis of:

By Application

> Immunoassays
> Dry Chemistry
> Chromogenic Substrates
> DNA Probes
> Biosensors
> Monoclonal and Polyclonal Antibodies
> Microcomputers
> Others

By End Users

> Hospitals
> Physician Offices
> Commercial Labs and Private Labs
> Ambulatory Care Centers
> Others

The anti-thrombin III market is majorly driven by increasing demand of coagulation testing for anti-thrombin III by end users such as hospitals and physician offices in developed geographies such as North America and Europe. In addition, consistent introduction of novel anti-thrombin III testing methods further drives the growth of the market. Several companies are offering effective and innovative anti-thrombin III testing techniques which would stimulate the market growth. For example, Siemens AG offers Berichrom Antithrombin III (A) reagent that effectively used for the inhibition of the thrombin factor. In addition, the company also offers Sysmex CA-600 Systems that provides efficient clotting, immunologic detection and chromogenic methods and provides easy to use features for the laboratory settings. Thus, this factor would in turn enhance the number of patients utilizing the anti-thrombin III testing methods hence drives the market growth. However, strict regulatory environment and high cost of anti-thrombin III will restrain the anti-thrombin III market growth.

Geographically, North America dominates the global market for Anti-thrombin III. The accelerated growth in North America for anti-thrombin III is mainly attributed to the rising demand of coagulation testing among the patient population coupled with increasing incidence of blood related problems in this region. This factor would in turn establish the healthy to develop the growth of the market hence drives the market growth. Europe is considered as the second largest market of anti-thrombin III owing to the launch of innovation and novel anti-thrombin III testing methods by key players of the market. Launch of new anti-thrombin III testing methods would in turn increase the uptake of these methods which would stimulates the market growth of anti-thrombin III in European region. In addition, India, South East Asia and China are the geographically emerging market for anti-thrombin III and considered to grow with the highest CAGR in near future. Cost effective production environment for biotechnology and pharmaceutical companies compared to developed countries like the U.S. and Europe will attract many biotechnology companies to increase their investment in Asia-Pacific region. Moreover, countries such as India and China would consider as the biggest market for anti-thrombin III due to the high demand for anti-thrombin III testing among the patient population in these regions.

Get accurate market forecast and analysis on the Anti-Thrombin III Testing Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5258

Various key players contributing to the global Anti-thrombin III market comprises Siemens AG, Trinity Biotech PLC, Sysmex Corporation and others.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Protein Analyzers Market is Anticipated To Witness Steady Demand In Developed Regions

Global Protein Analyzers Market: Synopsis 

The global protein analyzers market is popularized by a few dominating products manufactured by as dominant companies operating in the industry. For instance, Euro Vector’s N-Protein Analyzer is crucial for achieving accuracy and simplicity during the process of the determination of N-protein percentage. Flash 2000 N/Protein Analyzer by Thermo Fisher Scientific, Inc. is a great competition to the Kjeldahl method where it cuts down the analysis time to only a few minutes from many hours.

Browse through Protein Analyzers Market report to know what factors will shape the market by 2024: http://www.transparencymarketresearch.com/protein-analyzers-market.html

The global protein analyzers market could be segmented according to company, country, product, or application for interested parties to receive profitable insights into the industry. The report is just the right guideline to analyze each and every vital segment contributing its bit to the market.

The analysts have compiled this report while considering the immediate as well as future business needs of players participating in the global protein analyzers market. Important aspects such as trends and opportunities, growth factors, constraints, and competitive landscape are exhaustively studied in the publication.

Global Protein Analyzers Market: Key Trends 

The world protein analyzers market is envisioned to attract a sweeping measure of demand from the food and beverage sector as it witnesses a strong growth on the back of lifestyle changes, swelling global population size, and augmenting demand for healthy food products. The food and beverage sector has gained a telling impetus over the past half century on account of the rising number of restaurants and food outlets. For instance, Nestle, Starbucks, Coca Cola, KFC, McDonald’s, and other popular food hangouts are available in almost all countries across the world.

Flash 4000 N/Protein analyzer by Thermo Fisher Scientific, Inc. is a standout product in the global protein analyzers market that is capable of facilitating protein analysis from numerous samples in less than seven minutes. It is widely used during the manufacture of beer and more beverages, fertilizers, animal feed, and foods such as cereals, cheese, milk, and meat to analyze N-protein with the help of an effective combustion method.

On a global platform, the protein analyzers market could be optimistically influenced by the large-scale research and development activities practiced in the protein analyzer manufacturing sphere. This has led to the introduction of a variety of technologically sophisticated products in the industry.

Global Protein Analyzers Market: Geographical Study 

Owing to the advantage of a substantial and ballooning population base, Asia Pacific is envisaged to be a faster growing geographical segment in the international protein analyzers market. On the basis of revenue, Asia Pacific could hold the third largest share in the market, following North America and Europe. South Korea, Singapore, India, China, New Zealand, Australia, and Japan are the chief markets of Asia Pacific. North America and Europe, on the other hand, are foreseen to secure a larger market share due to the presence of a colossal number of food and beverage organizations and leading protein analyzer manufacturers.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Protein Analyzers Market by 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4315

Global Protein Analyzers Market: Competitive Scenario 

Large companies such as Life Technologies, Euro Vector, LECO Corporation, CE Elantech, Inc., VELP Scientifica, and Thermo Fisher Scientific, Inc. are anticipated to receive a tough competition from local players in developing markets such as South Africa, Brazil, China, and India. Besides this, the internal competition amongst these top players is foretold to aggravate the competitive scenario of the market.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Estimated to Flourish By 2023

Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Brief Account 

In autologous stem cell and non-stem cell based therapies, an individual’s cell is cultured and then re-introduced to the donor’s body. Used for the treatment of various bone marrow diseases, autologous stem cell and non-stem cell based therapies allows patients to have normal bone marrow, which gets destroyed in chemotherapy. The various diseases that can be treated with the help of autologous stem cell and non-stem cell based therapies include: multiple myeloma, aplastic anemia, non-Hodgkin’s lymphoma, Parkinson’s disease, Hodgkin’s lymphoma, thalassemia, and diabetes. Thus, the demand for this therapy is projected to rise over the coming years.

Browse through Autologous Stem Cell and Non-Stem Cell Based Therapies Market report to know what factors will shape the market by 2023: http://www.transparencymarketresearch.com/autologous-stem-cell-non-stem-cell-therapies-market.html

The report is a thorough analysis of the autologous stem cell and non-stem cell based therapies market. Comprising an in-depth analysis of the various factors boosting and inhibiting the growth of the market, this report is a key to making profitable decisions by investing in the correct segment and sub-segment, which is anticipated to make the most progress in the future.

Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Trends and Opportunities 

One of the key drivers for this market is the rise in the prevalence of cancer and diabetes among people across all age groups. Moreover, the growing geriatric population is another factor, which is likely to create a heightened demand for autologous stem cell and non-stem cell based therapies. Favorable reimbursement policies across several nations are also aiding the growth of this market.

Players in the market are striving to achieve therapies that are not only safe and effective but also affordable and easy to use. Players are also investing in extensive research and development so as to speed up the treatment process of autologous stem cell and non-stem cell based therapies. While currently this treatment is quite expensive, government bodies are expected to take up initiatives and make the therapy affordable in the years to come. This is expected to drive the market in the future.

On the other hand, challenges faced by the global autologous stem cell and non-stem cell based therapies market include risks and complications associated with the therapy, such as diarrhea, hair loss,  nausea, severe infections, vomiting, heart complications, and infertility.

Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Geographical Analysis 

By geography, North America, trailed by Europe is leading in the autologous stem cell and non-stem cell based therapies market, on account of the minimization of risks associated with the therapy. Also, these therapies are highly in demand owing to their ability to treat a large number of infectious diseases. The fact that autologous stem cell and non-stem cell based therapies do not require an outside donor, makes it more convenient and less infectious. All these factors are boosting the growth of the market in North America.

Asia Pacific is projected to show the most promising growth in the years to come with high demand from China, Vietnam, Malaysia, and India. The demand is expected to be high as autologous stem cell and non-stem cell based therapies help in the effective treatment of cardiovascular diseases. Sophisticated healthcare infrastructure and favorable tax and reimbursement policies are also expected to aid the growth of the Asia Pacific autologous stem cell and non-stem cell based therapies market.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Autologous Stem Cell and Non-Stem Cell Based Therapies Market by 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4001

Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Companies Mentioned

Some of the leading players operating in the autologous stem cell and non-stem cell based therapies market are Fibrocell Science, Inc., Aastrom Biosciences, Dendreon Corporation, NeoStem, Inc., BrainStorm Cell Therapeutics, Regeneus Ltd., and Genzyme Corporation.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Disposable Syringes Market: Need to Prepare for Influx of Injectable Drugs Increase the Demand

Global Disposable Syringes Market: Snapshot

The rapid increase in the number of injectable drugs to be approved recently has been a key contributor to the growth in demand for disposable syringes specifically, over other types of syringes. This is due to the growing number of patients afflicted with accidental needlestick injuries. Both factors thus work in tandem to create a staggering demand for disposable syringes and will continue to do so in the long term.

Browse through Disposable Syringes Market report to know what factors will shape the market by 2023: http://www.transparencymarketresearch.com/disposable-syringes-market.html

The number of disposable syringes being used has also increased due to the growth in point-of-care administration systems. These systems promote the self-administration of drugs, which can be easily done with modern disposable syringes with improved safety features.

The effective result of the above factors of influence on the market – along with a few others – for disposable syringes is expected to translate to a CAGR of 5.6% from 2015 to 2023. This market is expected to be valued above US$9.3 bn by the end of 2023 and close to US$6.5 bn by the end of 2016.

North America Remains Leading Disposable Syringe Consumer While Players Look to APAC for Bigger Opportunities

By the end of 2016, North America disposable syringe makers are expected to gain a revenue of US$3.9 bn, which is close to half of the total revenue earned on a global level. North America is expected to maintain its dominance over disposable syringes revenue till 2023, although it is expected to lose some percentage to the burgeoning Asia Pacific market. Europe will remain the second-largest region for disposable syringes till 2023. Both North America and Europe are showing a high demand for disposable syringes due to the growing number of injectable drugs in the market, improvements in syringe quality and safety through regulatory adherence, and the concern over a growing number of needlestick injuries.

China and India are expected to be the two key lucrative avenues for disposable syringes players in the near future, owing to their high population densities and growth in healthcare expenditures. A large part of this growth in demand for disposable syringes is attributed to the increasing number of government and private initiatives for conducting immunization drives across the countries. Additionally, the higher interest shown by North American and European players in these regions is expected to add to the quality of disposable syringes available in the market, further increasing their consumption rates.

Safety Syringes to Gain Larger Share

Conventional disposable syringes have held the larger share by volume till now, and will be expected to hold the dominant share for a few more years. However, the segment is expected to lose its leading position to safety syringes which are gaining popularity at a rapid pace. Safety syringes already lead the market in terms of value. By 2023, safety syringes are expected to hold a revenue share of 84%.

Key reasons for the high accelerated growth rate shown by safety syringes is the absence of any safety mechanisms in conventional ones. Safety syringes help protect patients from needlestick injuries and are just as accurate and easy to use as conventional disposable syringes.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Disposable Syringes Market by 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1259

The top manufacturers of disposable syringes in the world today include Becton, Dickinson & Company, B. Braun Melsungen AG, Medtronic plc, Terumo Corporation, Smiths Medical, and Retractable Technologies, Inc.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Spinal Trauma Devices Market to Surge Rapidly in Response to Rising Spinal Injuries

The global spinal trauma devices market is dynamic and highly competitive. Only a couple of companies account for a substantial share in the market, thus lending it an oligopolistic vendor landscape. The market is largely dominated by DePuy Synthes, Medtronic, NuVasive, Inc., Stryker Corporation, and Globus Medical, Inc. The cumulative share of these companies added up to 79.1% in 2014, says Transparency Market Research (TMR) in a new report.

Browse through Spinal Trauma Devices Market report to know what factors will shape the market by 2023: http://www.transparencymarketresearch.com/spinal-trauma-devices-market.html

As per TMR, the rivalry amongst the leading players is expected to intensify further in response to the increasing demand for technologically advanced medical devices. Product innovation is thus regarded as the most popular strategy by key players to establish a stronger presence in the market. Besides this, most of the top companies have operations concentrated in specific regions, which has led to market saturation. Spurred by these factors, the competition prevailing in the market is not likely to subside during the report’s forecast period from 2015 to 2023.

Growing Awareness about Minimally Invasive Surgeries Fuels Demand for Spinal Trauma Devices

As per the WHO’s estimates, every year between 250,000 to 500,000 people suffer from spinal injuries. Violence, traffic crashes, industrial accidents and road accidents are among the most common causes of such injuries. Such increasing incidence of spinal injuries is the primary factor fuelling demand for spinal trauma devices globally. These incidents mostly lead to hospitalization, thus fuelling demand for effective treatments, which are not possible sans spinal trauma devices.

Furthermore, since bone density decreases with age making the geriatric population more prone to fractures, this demographic is likely to make a sizeable contribution to the demand for spinal trauma devices. The rising incidence of osteoporosis is also fueling demand from the spinal trauma devices market.

As per a lead TMR analyst, “In the forthcoming years, the demand for minimally invasive procedures is set to rise considerably as patients become more informed about the recent medical advances. This trend has encouraged the development of new technological advancements in spinal trauma devices. Since minimally invasive spinal trauma devices ensure faster recovery, their demand is expected to surge rapidly in the near future.”

Absence of Proper Insurance Schemes Limiting Scope for Growth in Developing Economies

On the flip side, the absence of proper health insurance schemes is limiting the scope for expansion of the spinal trauma devices market across developing countries. With the majority of the population in emerging nations such as India and China still lacking access to primary healthcare facilities, the spinal trauma devices market witnesses a tough environment to expand their footprint in.

However, the gradual increase in healthcare spending will augment sales opportunities for spinal trauma devices manufacturers. “Many governments are pushing for state-funded insurance to provide efficient healthcare facilities. The demand for advanced medical devices is poised to rise considerably as a result of this. This will fuel sales of spinal trauma devices,” said the TMR analyst.

Spinal Trauma Devices Sales to Gain Momentum with Advent of Bioresorbable Implants

The drawbacks associated with conventional metal devices demand the use of bioresorbable implants for the treatment of spinal injuries. Bioresorbable implants are assimilated by the tissues, thereby eliminating the need for follow-up surgeries most commonly associated with metallic fixators. This transition has been creating significant scope for the market’s expansion. Furthermore, spinal trauma devices manufacturers are also likely to find lucrative opportunities in emerging nations such as India, Brazil, China, Mexico, and others.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving Spinal Trauma Devices Market by 2023: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7613

As per TMR, the global spinal trauma devices market stood at US$2.8 bn in 2014. Rising at a CAGR of 5.6% between 2015 and 2023, the market is expected to reach US$4.7 bn by the end of 2023. By type, internal fixation devices led the market in 2014. The segment is expected to surge at a CAGR of 6.1% between 2015 and 2023. Regionally, North America led the global spinal trauma devices market in 2014 with a share of 47%.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/